Coverage details for antiviral medications prescribed for the treatment of COVID-19, specifically those like Paxlovid, vary depending on the specific Medicare plan a beneficiary holds. Original Medicare (Part A and Part B) typically does not directly cover outpatient prescription drugs. Therefore, coverage often relies on enrollment in a Medicare Part D plan or a Medicare Advantage plan that includes prescription drug coverage.
Access to COVID-19 treatments is a critical aspect of public health, particularly for vulnerable populations. Understanding the nuances of Medicare coverage ensures beneficiaries can access necessary medications in a timely and affordable manner. Historically, during the public health emergency, the federal government purchased and provided Paxlovid free of charge. As the emergency declaration ended, the responsibility for coverage shifted, requiring individuals to navigate the existing Medicare framework.
